Literature DB >> 20522718

Riding the 2-edged sword.

Alexander Egle1.   

Abstract

Year:  2010        PMID： 20522718     DOI： 10.1182/blood-2010-03-272211

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  1 in total

1.  Dual targeting of PI3K and BCL-2 overcomes ibrutinib resistance in aggressive mantle cell lymphoma.

Authors:  Haige Ye; Shengjian Huang; Yang Liu; Zhihong Chen; Michael Wang; Vivian Changying Jiang
Journal:  J Cell Mol Med       Date:  2022-03-30       Impact factor: 5.295
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.